{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:40:33Z","timestamp":1790404833823,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012781","name":"MSD K.K.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.metabol.2020.154405","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T05:03:00Z","timestamp":1602824580000},"page":"154405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Sodium-glucose cotransporter 2 inhibition attenuates protein overload in renal proximal tubule via suppression of megalin O-GlcNacylation in progressive diabetic nephropathy"],"prefix":"10.1016","volume":"113","author":[{"given":"Hitomi","family":"Otomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiko","family":"Nara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Suganuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Morii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2020.154405_bb0005","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2337\/db16-0796","article-title":"Proximal tubulopathy: prime mover and key therapeutic target in diabetic kidney disease","volume":"66","author":"Gilbert","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2020.154405_bb0010","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.semnephrol.2012.07.008","article-title":"Can we target tubular damage to prevent renal function decline in diabetes?","volume":"32","author":"Bonventre","year":"2012","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.metabol.2020.154405_bb0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.matbio.2018.02.006","article-title":"Renal fibrosis: Primacy of the proximal tubule","volume":"68\u201369","author":"Gewin","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.metabol.2020.154405_bb0020","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40620-017-0423-9","article-title":"A more tubulocentric view of diabetic kidney disease","volume":"30","author":"Zeni","year":"2017","journal-title":"J Nephrol"},{"key":"10.1016\/j.metabol.2020.154405_bb0025","doi-asserted-by":"crossref","first-page":"F145","DOI":"10.1152\/ajprenal.00164.2016","article-title":"The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction","volume":"311","author":"Chevalier","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.metabol.2020.154405_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.kint.2015.11.007","article-title":"Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease","volume":"89","author":"Nielsen","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2020.154405_bb0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/membranes4030333","article-title":"The endocytic receptor megalin and its associated proteins in proximal tubule epithelial cells","volume":"4","author":"De","year":"2014","journal-title":"Membranes (Basel)"},{"key":"10.1016\/j.metabol.2020.154405_bb0040","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1073\/pnas.79.18.5557","article-title":"The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border","volume":"79","author":"Kerjaschki","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2020.154405_bb0045","doi-asserted-by":"crossref","first-page":"F857","DOI":"10.1152\/ajprenal.00203.2014","article-title":"Mitochondrial dysfunction confers albumin-induced NLRP3 inflammasome activation and renal tubular injury","volume":"308","author":"Zhuang","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.metabol.2020.154405_bb0050","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/ki.2012.475","article-title":"Selective estrogen receptor modulation attenuates proteinuria-induced renal tubular damage by modulating mitochondrial oxidative status","volume":"83","author":"Nishi","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2020.154405_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072344","article-title":"Involvement of endoplasmic reticulum stress in albuminuria induced inflammasome activation in renal proximal tubular cells","volume":"8","author":"Fang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2020.154405_bb0060","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1038\/s41598-019-43730-5","article-title":"Dipeptidyl peptidase-4 plays a pathogenic role in BSA-induced kidney injury in diabetic mice","volume":"9","author":"Takagaki","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2020.154405_bb0065","doi-asserted-by":"crossref","first-page":"F456","DOI":"10.1152\/ajprenal.00403.2005","article-title":"Tubular kidney injury molecule-1 in protein-overload nephropathy","volume":"291","author":"van Timmeren","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.metabol.2020.154405_bb0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2020.154405_bb0075","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2020.154405_bb0080","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2020.154405_bb0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2020.154405_bb0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2337\/dbi18-0007","article-title":"Sodium-glucose Cotransporter 2 inhibition and diabetic kidney disease","volume":"68","author":"Alicic","year":"2019","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2020.154405_bb0095","doi-asserted-by":"crossref","first-page":"C1174","DOI":"10.1152\/ajpcell.00450.2011","article-title":"Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences","volume":"302","author":"Sabolic","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.metabol.2020.154405_bb0100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1681\/ASN.2010030246","article-title":"SGLT2 mediates glucose reabsorption in the early proximal tubule","volume":"22","author":"Vallon","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2020.154405_bb0105","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.2337\/db17-0100","article-title":"Empagliflozin and kinetics of renal glucose transport in healthy individuals and individuals with type 2 diabetes","volume":"66","author":"Al-Jobori","year":"2017","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2020.154405_bb0110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1210\/en.2005-0523","article-title":"Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells","volume":"147","author":"Goldberg","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2020.154405_bb0115","doi-asserted-by":"crossref","first-page":"E424","DOI":"10.1152\/ajpendo.00382.2002","article-title":"High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin","volume":"284","author":"Walgren","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2020.154405_bb0120","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cardiores.2006.07.018","article-title":"Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system","volume":"73","author":"Fulop","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2020.154405_bb0125","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nrm.2017.22","article-title":"Protein O-GlcNAcylation: emerging mechanisms and functions","volume":"18","author":"Yang","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.metabol.2020.154405_bb0130","doi-asserted-by":"crossref","first-page":"1308692","DOI":"10.1155\/2017\/1308692","article-title":"The role of stress-induced O-GlcNAc protein modification in the regulation of membrane transport","volume":"2017","author":"Fisi","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.metabol.2020.154405_bb0135","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nature05815","article-title":"Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins","volume":"446","author":"Hart","year":"2007","journal-title":"Nature."},{"key":"10.1016\/j.metabol.2020.154405_bb0140","first-page":"96","article-title":"O-linked beta-N-acetylglucosamine (O-GlcNAc): extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress","volume":"2010","author":"Butkinaree","year":"1800","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2020.154405_bb0145","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1681\/ASN.2008080844","article-title":"Reduction of renal superoxide dismutase in progressive diabetic nephropathy","volume":"20","author":"Fujita","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2020.154405_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1172\/JCI4431","article-title":"A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse","volume":"103","author":"Wang","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2020.154405_bb0155","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/diabetes.54.9.2628","article-title":"Characterization of susceptibility of inbred mouse strains to diabetic nephropathy","volume":"54","author":"Qi","year":"2005","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2020.154405_bb0160","doi-asserted-by":"crossref","first-page":"F590","DOI":"10.1152\/ajprenal.00324.2003","article-title":"Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance","volume":"286","author":"Qi","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.metabol.2020.154405_bb0165","doi-asserted-by":"crossref","first-page":"F1151","DOI":"10.1152\/ajprenal.00596.2011","article-title":"Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse","volume":"302","author":"Tanabe","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2020.154405_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000327564","article-title":"Using stereologic techniques for podocyte counting in the mouse: shifting the paradigm","volume":"33","author":"Nicholas","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.metabol.2020.154405_bb0175","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/phar.1903","article-title":"Impact of sodium-glucose cotransporter 2 inhibitors on nonglycemic outcomes in patients with type 2 diabetes","volume":"37","author":"Trujillo","year":"2017","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.metabol.2020.154405_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/cells7060053","article-title":"The nutrient-sensing hexosamine biosynthetic pathway as the hub of cancer metabolic rewiring","volume":"7","author":"Chiaradonna","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.metabol.2020.154405_bb0185","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1074\/jbc.RA119.010565","article-title":"First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in ex vivo mouse heart","volume":"295","author":"Olson","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2020.154405_bb0190","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrneph.2017.107","article-title":"Mitochondrial energetics in the kidney","volume":"13","author":"Bhargava","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.metabol.2020.154405_bb0195","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1242\/jcs.02537","article-title":"Regulation of mitochondrial fission and apoptosis by the mitochondrial outer membrane protein hFis1","volume":"118","author":"Yu","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.metabol.2020.154405_bb0200","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/978-981-13-8871-2_29","article-title":"Oxidative stress and renal fibrosis: mechanisms and therapies","volume":"1165","author":"Su","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.metabol.2020.154405_bb0205","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/hr.2010.9","article-title":"Mechanisms of obesity-induced hypertension","volume":"33","author":"Kotsis","year":"2010","journal-title":"Hypertens Res"},{"key":"10.1016\/j.metabol.2020.154405_bb0210","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.HYP.35.5.1135","article-title":"Weight gain-induced blood pressure elevation","volume":"35","author":"Masuo","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2020.154405_bb0215","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.113.005081","article-title":"Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus","volume":"129","author":"Cherney","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2020.154405_bb0220","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1681\/ASN.V10122569","article-title":"Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption","volume":"10","author":"Vallon","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2020.154405_bb0225","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0167-4838(00)00152-7","article-title":"Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse","volume":"1482","author":"Kjeldsen","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2020.154405_bb0230","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1097-2765(02)00708-6","article-title":"The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition","volume":"10","author":"Goetz","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.metabol.2020.154405_bb0235","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1023\/A:1003708808934","article-title":"Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression","volume":"31","author":"Friedl","year":"1999","journal-title":"Histochem J"},{"key":"10.1016\/j.metabol.2020.154405_bb0240","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ki.2008.499","article-title":"Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons","volume":"75","author":"Kuwabara","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2020.154405_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148043","article-title":"Urine\/plasma neutrophil gelatinase associated lipocalin ratio is a sensitive and specific marker of subclinical acute kidney injury in mice","volume":"11","author":"Kaucsar","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.metabol.2020.154405_bb0250","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1681\/ASN.2018090950","article-title":"Protein O-GlcNAcylation is essential for the maintenance of renal energy homeostasis and function via lipolysis during fasting and diabetes","volume":"30","author":"Sugahara","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2020.154405_bb0255","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.lfs.2009.01.007","article-title":"Evidence of O-linked N-acetylglucosamine in diabetic nephropathy","volume":"84","author":"Degrell","year":"2009","journal-title":"Life Sci"},{"key":"10.1016\/j.metabol.2020.154405_bb0260","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1074\/jbc.M117.817981","article-title":"Site-specific O-glycosylation of members of the low-density lipoprotein receptor superfamily enhances ligand interactions","volume":"293","author":"Wang","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2020.154405_bb0265","doi-asserted-by":"crossref","first-page":"12749","DOI":"10.1074\/jbc.RA118.001746","article-title":"O-GlcNAcylation reduces proximal tubule protein reabsorption and promotes proteinuria in spontaneously hypertensive rats","volume":"293","author":"Silva-Aguiar","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2020.154405_bb0270","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1681\/ASN.2015101168","article-title":"Increase of total nephron albumin filtration and reabsorption in diabetic nephropathy","volume":"28","author":"Mori","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2020.154405_bb0275","doi-asserted-by":"crossref","first-page":"26428","DOI":"10.1038\/srep26428","article-title":"Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db\/db mice","volume":"6","author":"Gallo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2020.154405_bb0280","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1038\/s41598-018-22229-5","article-title":"Comprehensive renoprotective effects of ipragliflozin on early diabetic nephropathy in mice","volume":"8","author":"Kamezaki","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2020.154405_bb0285","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1038\/s41598-019-41253-7","article-title":"Amelioration of diabetic nephropathy by SGLT2 inhibitors independent of its glucose-lowering effect: a possible role of SGLT2 in mesangial cells","volume":"9","author":"Maki","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2020.154405_bb0290","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1007\/s00125-016-4008-2","article-title":"The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes","volume":"59","author":"Cherney","year":"2016","journal-title":"Diabetologia."},{"key":"10.1016\/j.metabol.2020.154405_bb0295","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.kint.2016.06.012","article-title":"Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy","volume":"90","author":"Takashima","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2020.154405_bb0300","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.biopha.2018.10.100","article-title":"Dapagliflozin attenuates early markers of diabetic nephropathy in fructose-streptozotocin-induced diabetes in rats","volume":"109","author":"Oraby","year":"2019","journal-title":"Biomed Pharmacother"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049520302699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049520302699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T14:48:12Z","timestamp":1669214892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049520302699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":60,"alternative-id":["S0026049520302699"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154405","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium-glucose cotransporter 2 inhibition attenuates protein overload in renal proximal tubule via suppression of megalin O-GlcNacylation in progressive diabetic nephropathy","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154405"}}